Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Samuel Baxter

Adult Reconstructive Orthopaedic Surgery Little Rock, AR Medical Doctor

NPI 1902292360 CMS profile 8373268

5320 W Markham St, Little Rock, AR 72205

Open in the dashboard

General payments

$10,865

76 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Samuel Baxter of Little Rock, AR is reported in the CMS Open Payments database as having received $10,865 across 76 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 50th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,348 22
2024 General $1,175 10
2023 General $1,569 15
2022 General $3,178 10
2021 General $2,565 17
2020 General $28 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Samuel Baxter
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Samuel Baxter were reported at $2,348. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Samuel Baxter Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $0 $1,416 $292–$9,336 $163
2020 $28 $647 $141–$6,474 $114
2021 $2,565 $1,073 $211–$6,497 $132
2022 $3,178 $1,217 $236–$6,299 $149
2023 $1,569 $1,082 $246–$6,818 $160
2024 $1,175 $1,575 $323–$8,944 $164
2025 $2,348 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medacta USA, Inc. $8,122 41 payments
  2. Zimmer Biomet Holdings, Inc. $1,833 15 payments
  3. Stryker Corporation $309 6 payments
  4. Molnlycke Health Care US, LLC $224 1 payment
  5. Next Science LLC $116 1 payment
  6. Vertex Pharmaceuticals Incorporated $72 3 payments
  7. DePuy Synthes Sales Inc. $45 3 payments
  8. Innovation Technologies Inc $45 2 payments
  9. Heron Therapeutics, Inc. $44 1 payment
  10. Bioventus LLC $32 2 payments
  11. Other $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Travel and Lodging $7,642 31 payments
  2. Food and Beverage $2,623 43 payments
  3. Consulting Fee $500 1 payment
  4. Education $100 1 payment
Products named General payments · program years 2020–2025
  1. AMISTEM $3,973 16 payments
  2. Arcos $1,411 11 payments
  3. GMK SPHERE Knee $1,369 6 payments
  4. GMK Sphere Orthopedics/Orthopedic Surgery $1,046 3 payments
  5. AMIStem H Femoral Stems $846 5 payments
  6. SPHERIKA $703 8 payments
  7. Mepilex Border Post-Op $671 3 payments
  8. Mepilex Border Post-Op Ag $447 2 payments
  9. GMK Sphere Revision System $151 2 payments
  10. MAKO $147 1 payment
  11. Other $1,038 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

335

Median for Orthopedic Surgery: 203

Drug cost

$1,968

Median for Orthopedic Surgery: $1,433

Branded share of claims

3.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 183 $1,121
Celecoxib Generic 14 $246
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 13 $163
Oxycodone Hcl Generic 31 $152
Methylprednisolone Generic 30 $137
Meloxicam Generic 21 $101
Amoxicillin Generic 43 $48

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$247,519

Of which drugs: $4,187

Medicare patients

538

Average age 74

Services billed

3,287

316 women, 222 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 34%
Diabetes 25%
Depression 24%
Chronic kidney disease 17%
Atrial fibrillation 15%
Cancer 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 153 1,043 $727

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

76 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Arkansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record